The U.S. Food and Drug Administration (FDA) has greenlighted Medtronic’s (NYSE:MDT) PulseSelect Pulsed Field Ablation (PFA) System targeted at a heart rhythm ... that the device will be ...

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...

Medical technology giant Medtronic will purchase miniaturised heart device firm, Heartware, in a deal worth an estimated $1.1 billion. The deal will see Heartware’s expansive range of ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.

Bengaluru: The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal heart rhythm, the company said on Thursday. The device ...

The Sphere-9 catheter (Medtronic) Medtronic said its PulseSelect system, the first pulsed field ablation device approved by ... tachycardia in patients whose heart tissue has been scarred from ...

At the same time, a CT scan mapped the geometry of the heart. When combined ... to a lightweight disposable device with 250 adhesive-backed electrodes. To hear the founders retell the story, the sale ...

The HxM™ BT combines Zephyr’s patented BioHarness™ smart-fabric heart rate technology used in high-end professional markets, with speed and distance in a small, comfortable consumer device.

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Medical technology giant Medtronic will purchase miniaturised heart device firm, Heartware, in a deal worth an estimated $1.1 billion. The deal will see Heartware’s expansive range of ...